Progressive supranuclear palsy (PSP), initially called Steele-Richardson-Olszewski syndrome, is a sporadic neurodegenerative disease.
Matthew R. Burns, MD, PhD
Advertisement
Articles by Matthew R. Burns, MD, PhD
Advertisement
Latest Updated Articles
Diagnosis of Progressive Supranuclear PalsyFebruary 8th 2018
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
2
Using Serum Biomarkers to Monitor Multiple Sclerosis Disease Activity: Darin T. Okuda, MD, FAAN, FANA
3
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
4
Tolebrutinib Approved in EU for Nonrelapsing Secondary Progressive MS, Marking First Disability-Targeting Therapy in the Indication
5